England Kristin 4

What Happened
Kristin England, Chief Administrative Officer of Oncology Institute, Inc. (TOI), was granted 55,743 restricted stock units (RSUs) on March 27, 2026. The Form 4 reports the award as acquired at $0.00 (i.e., an RSU grant rather than a purchase); no immediate cash value or sale was reported.

Key Details

• Transaction date: March 27, 2026; filing date: April 1, 2026 (filed 5 days after the transaction). Form 4s are generally due within two business days, so this filing is later than the typical reporting window.
• Shares/units granted: 55,743 RSUs; reported acquisition price: $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The award is subject to a standard four-year vesting schedule — 1/4 of the RSUs vest on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments thereafter, and full vesting on the fourth anniversary, subject to continued service.

Context
RSU grants are a form of compensation and do not represent immediately tradable shares until they vest. This is a grant (compensation) event rather than a market purchase or sale, so it primarily reflects company compensation practices rather than an immediate insider market view.